Your browser doesn't support javascript.
loading
Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists.
Hill, Matthew D; Fang, Haiquan; King, H Dalton; Iwuagwu, Christiana I; McDonald, Ivar M; Cook, James; Zusi, F Christopher; Mate, Robert A; Knox, Ronald J; Post-Munson, Debra; Easton, Amy; Miller, Regina; Lentz, Kimberley; Clarke, Wendy; Benitex, Yulia; Lodge, Nicholas; Zaczek, Robert; Denton, Rex; Morgan, Daniel; Bristow, Linda; Macor, John E; Olson, Richard.
Affiliation
  • Hill MD; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Fang H; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • King HD; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Iwuagwu CI; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • McDonald IM; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Cook J; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Zusi FC; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Mate RA; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Knox RJ; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Post-Munson D; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Easton A; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Miller R; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Lentz K; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Clarke W; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Benitex Y; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Lodge N; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Zaczek R; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Denton R; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Morgan D; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Bristow L; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Macor JE; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
  • Olson R; Bristol-Myers Squibb Research and Development , 5 Research Parkway, Wallingford, Connecticut 06492-7660, United States.
ACS Med Chem Lett ; 8(1): 133-137, 2017 Jan 12.
Article in En | MEDLINE | ID: mdl-28105289

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ACS Med Chem Lett Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ACS Med Chem Lett Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States